| Application no. and date | 10814595.4 (espacenet) (Federated) (European Patent Register), 20100903 | | Patent/reg. no. and date | DK/EP 2473170, 20190619 | | Publication date | 20120711 | | Priority no. and date | US 240092 P, 20090904, US 249231 P, 20091006 | | EP pub. no. and date |
EP 2473170 20120711 | | Effective date | | | Applicant/owner | Horizon Therapeutics U.S. Holding LLC, 1 Horizon Way
Deerfield
Illinois 60015, US | | Applicant ref. no. | P69119DK01 | | Inventor | DUDLEY, Michael, N., 17257 Silver Gum Way
San Diego
CA 92127, US,
GRIFFITH, David, C., 714 Bandak Court
San Marcos
CA 92069, US,
MORGAN, Elizabeth, E., 2901 Lawrence Lane
Escondido
CA 92025, US,
LOUTIT, Jefferey, S., 1190 Brucito Ave.
Los Altos
CA 94024, US,
LOMOVSKAYA, Olga, 49 Showers Drive
Apt. No.J-318
Mountain View
CA 94040, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/5383 (2006.01) , A61K 33/06 (2006.01) , A61K 9/12 (2006.01) , A61P 11/00 (2006.01) | | Title | ANVENDELSE AF AEROSOLISERET LEVOFLOXACIN TIL BEHANDLING AF CYSTISK FIBROSE | | Int. application no. | US2010047903 | | Int. publication no. | WO2011029059 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
